Will Epigenetics Give Rise to the Next 'BGI Genomics'?

All living beings are imbued with vitality, and the complexity and intricacy of life often surpass our imagination. Seemingly minor anomalies and changes in organisms can give rise to a flourishing frontier discipline. The following phenomena from everyday life may pique your interest:

○ Calico cats carry genes for both yellow and black coat colors. According to the central dogma, when a female cat’s two X chromosomes carry the yellow and black genes respectively, her fur should exhibit a mixture of black and yellow, resulting in a brown color.Why are calico cats ultimately yellow and black, rather than brown?

○ In a honeybee colony, both worker bees and the queen bee develop from female larvae. However, the queen bee is solely responsible for laying eggs to reproduce, while worker bees are dedicated to labor. The queen bee can live for several years, whereas worker bees only survive for a few months.What exactly is the “mysterious force” that determines their vastly different developmental outcomes?

○ During the final stages of World War II, the Dutch experienced a period known as “The Hunger Winter.” Evidence suggests that this famine left an imprint on genetic material. Children born to women who were pregnant during the severe famine tended to have lower birth weights and smaller body sizes.Can the Effects of Famine on People Be Inherited?

These issues can all be addressed with a singleexplained using knowledge from the niche field of epigenetics,We will conduct a detailed analysis of each point in the text.

When “heredity” and “genes” are mentioned, many people’s first thought is likely the long DNA strands with their double-helix structure, where the arrangement and combination of bases carry the “code” of our lives. However,In addition to the DNA sequence, another set of mechanisms is at play.It acts as an information filter, controlling which parts of the DNA sequence are expressed and which become silent “non-functional information.”

In the field of biomedicine, epigenetic research holds significant importance. It can help usConquering the Challenges in Tumor Therapy, such as delaying the development of tumor drug resistance and enhancing tumor sensitivity to medications. It also facilitates our researchLupus, Alzheimer's Disease, Parkinson's Diseasecomplex diseases caused by abnormal epigenetic modifications, understand their pathogenic mechanisms, and discover new therapeutic drugs.

Currently, compared with genomics, the overall development of epigenetics is still in its early stages, with progress concentrated mainly in academia and limited industrial translation into clinical testing and drug development. However, we believe that as technology advances, research methodologies in epigenetics will undergo iterative improvements and become more widely adopted, leading to more scientific breakthroughs in this field in the future. Meanwhile, the therapeutic needs for complex and refractory diseases will also drive biomedical researchers to continue exploring related directions.

In this article, you will read:

○ Why can't DNA sequences fully determine an organism's phenotypic traits?

How Epigenetics Helps Us Conquer MalignancyTumors, Alzheimer's Diseasesuch as complex diseases?

○ In the field of epigenetics, the next one will emerge"BGI Genomics"?

○ Epigenetics in Academic and Industrial SectorsDevelopment ProspectsHow is it?

○ In the field of epigenetics, what are theEntrepreneurship and Investment Opportunities?

We hope this brings a new perspective. If you are an entrepreneur or practitioner in the field of epigenetics, you are welcome to contact the author of this article,Xie Da, Vice President of FreeS Fund (xie.da@freesvc.com)

“Epigenetics” may sound unfamiliar to many. However, the following everyday phenomena might pique your interest.

The first phenomenon is calico cats.Calico cats are all female and feature three coat colors: white, yellow, and black. Interestingly, the genes responsible for black and yellow fur are dominant alleles located on the X chromosome of female cats. According to the central dogma, when a female cat’s two X chromosomes carry the yellow and black genes respectively, her coat should exhibit a blend of black and yellow, resulting in brown. However, calico cats display distinct patches of yellow and black, indicating that their fur selectively expresses only one of these colors.。How Is the Unique Coat Color of Calico Cats Formed?

▲ Calico cat. Image source: Unsplash

The second phenomenon is bees.In a honeybee colony, both worker bees and the queen are female, yet they differ significantly. The queen is solely responsible for laying eggs to reproduce, while worker bees, which are sterile, handle tasks both inside and outside the hive, such as foraging for food, building the honeycomb, and nursing larvae. Queens live for several years, whereas worker bees survive only a few months. The primary factor determining whether a female larva develops into a worker bee or a queen is diet: female larvae fed exclusively on royal jelly develop into queens, while those fed royal jelly for the first three days and subsequently fed honey and pollen develop into worker bees.Why Can Royal Jelly Determine the Developmental "Fate" of Larval Bees?

▲ Busy worker bees. Image source: Unsplash

The third phenomenon is the "Dutch Hunger Winter" in the late stages of World War II.In the Netherlands during the late stages of World War II, the government-in-exile, anticipating the imminent collapse of Germany, organized a nationwide strike. In retaliation, the Nazis cut off food supplies to the Netherlands from the winter of 1944 to April 1945, resulting in 20,000 deaths. This period is known by the Dutch as the “Hunger Winter.” Nearly 80 years have passed since the “Hunger Winter,” yet unfortunately, the famine appears to have been recorded in our genetic material, as children born to women who were pregnant during the great famine tend to have smaller body sizes.Can the effects of famine on people be inherited?

▲ Women and children during the Dutch famine of 1944. Image source: Columbia Magazine

The above examples can all be explained using knowledge of epigenetics.

Epigenetics refers to regulatory mechanisms that are above and beyond the genome,Epigenetics, where the prefix "epi-" means "above" or "outside." As the name suggests, epigenetics studies both the regulatory mechanisms of "epigenetic" phenomena and how these regulatory patterns are inherited.

So, why are we focusing on epigenetics now?

First, from the perspective of changes in population age structure and disease spectrum, the average life expectancy in China has exceeded 78 years. With population aging, diseases represented by neurological and psychiatric disorders, diabetes, and cancer have becomeChronic Non-Communicable Diseaseshave become the major diseases affecting the health of Chinese residents. These diseases are often caused by a dysregulation in the interaction between the human body and the environment. AsResearch on the Interaction Between Gene Expression in Living Organisms and the External EnvironmentEpigenetics, as a discipline, aligns closely with the pathogenic mechanisms of this class of diseases, offering new perspectives for their diagnosis, treatment, and drug development.

Secondly,From the Perspective of Drug Development, current developers are increasingly focusing onThe "selectivity" of the therapy's action at the lesion site,This enables drugs to act more precisely on the pathological site, without affecting other healthy organs and functions. The essence of epigenetics lies in the regulation of gene expression, a characteristic that providesImproving the aforementioned “selectivity” provides new approaches.

For example,By targeting epigenetic modulators,It can enhance tumor sensitivity to therapeutic agents, overcome tumor drug resistance and even metastasis, thereby demonstrating the advantages of combination therapy. Furthermore, in gene therapy drugs, the use of epigenetic elements can improve drug precision, aligning their functional effects more closely with human physiology. In the future, the value and potential of epigenetic research in precision medicine will continue to be explored.

Third,Epigenetics Is Still in Its Early Stages, with Considerable PotentialOver the past few decades, Chinese scientists have made substantial contributions to the field of epigenetics, including elucidating the establishment and demethylation of DNA methylation in mammals, discovering various histone demethylases, and advancing RNA epigenetics. In the future, this field will continue to make steady progress.，A series of novel epigenetic mechanisms remain to be discovered, imaging and sequencing tools will continue to evolve toward greater efficiency and lower cost, and the variety and formulations of clinically available drugs will also undergo continuous innovation.

Compared with epigenetics, “heredity” and the “central dogma” are concepts that may be more familiar to people.Central DogmaIt refers to the flow of genetic information from DNA to RNA and then to proteins.The existence of the central dogma often leads people to believe that the genomic DNA sequence determines all phenotypes of an organism.Meanwhile, owing to the stability of DNA sequences, these phenotypic traits can be stably inherited across multiple generations. The application of technologies such as gene editing also holds promise for treating genetic disorders caused by single-gene mutations, such as sickle cell anemia and cystic fibrosis.

In fact,The properties of certain organisms appear not to follow the traditional central dogma.In the absence of alterations in the DNA sequence or loss of biological elements that initiate gene expression,Alterations in the regulation of DNA expression,This results in different phenotypes among individuals and their cells. Moreover, certain differences can be inherited by the next generation or daughter cells.It is akin to playing poker: while the players and the cards remain unchanged, altering the sequence in which the cards are played can lead to different outcomes.

These phenomena beyond the central dogma are often the focus of epigenetics.

Epigenetic Landscape MapVividly illustrates the concept of "epigenetic." The figure analogizes gene expression to an iron ball rolling down a hillside, with different regulatory factors corresponding to different slopes.The contours of these hillsides influence which valley the small ball lands in, that is, how it is expressed.

At the microscopic level, the focus of epigenetics research isChromatin, more precisely, changes in chromatin structure that do not depend on alterations in the DNA sequence.

Chromatin contains an individual's genetic information and is composed of DNA and histones. The basic structural unit of chromatin is the nucleosome, a disc-shaped structure formed by DNA wrapping twice around histones. Human DNA stretches to 2 meters in length when fully extended, whereas the cell nucleus has a diameter of only 6 micrometers.It is equivalent to packing a 40-kilometer-long line into a tennis ball.Clearly, the transition from nucleosomes to chromatin involves numerous highly ordered folding steps.

At various levels, chromatin structure is closely associated with the regulation of DNA expression.Structure of ChromatinTo some extent, gene expression is subject to selection. In regions where chromatin is tightly folded, gene regulatory elements have limited accessibility, thereby restricting gene expression. Conversely, in regions with a more open chromatin structure, gene expression is relatively active.

At the microscopic scale, there are three main factors that regulate chromatin structure, thereby altering gene expression. They are,DNA Methylation, Histone Modification, and Non-coding RNA. These are the three most important mechanisms by which epigenetics influences individual phenotypes。Together, these three factors determine chromatin structure, thereby influencing gene expression.

◆ DNA Methylation Modification

DNA methylation modification is currently beingthemWell-studied epigenetic mechanisms.

DNA methylation refers to the process by which a methyl group (-CH3) is attached to the 5' position of specific cytosine bases in DNA, catalyzed by DNA methyltransferases. In mammals, this modification predominantly occurs at cytosine-guanine (CpG) dinucleotide sites. Methylation provides specific molecular conformational information and steric hindrance through a simple chemical mark, typically enablingInhibit the binding of transcription factors and suppress gene expression.

In the example of bee development,Differences in DNA methylation modifications caused by dietary variations may be an important factor contributing to divergent developmental outcomes in female larvae.Experimental observations revealed that worker bees and queen bees exhibit differential methylation states in over 550 genes.Royal jelly can reduce the methylation levels in female larvae,This promotes the development of complete ovarian tissue in larvae, ultimately resulting in queen bees. In contrast, larvae that consume honey during later stages maintain higher levels of DNA methylation and eventually develop into worker bees. Interestingly, artificial reduction of DNA methylation levels in female larvae also promotes a queen-like phenotype.

Humans possess two sets of chromosomes, inherited from the father and mother, respectively. According to Mendelian laws of inheritance, the expression of both paternal and maternal genes jointly determines the traits of offspring. However, in reality, there exists a special class of genes within the human body known as imprinted genes, which selectively express only the allele derived from either the father or the mother. As a result, the traits associated with these genes are determined solely by one parent.

The factors contributing to this difference in expression lie in the distinct methylation states of the regulatory regions of paternally and maternally imprinted genes, which alter gene expression. Consequently, only one parent influences the offspring’s traits. Therefore, by examining the expression patterns of imprinted genes on chromosomes, one can infer whether a chromosome is of paternal or maternal origin.Imprinted genes are currently also applied in kinship analysis and forensic investigations.

Insulin-like Growth Factor Igf2is one of the most thoroughly studied imprinted genes to date,This provides an explanation for the developmental delays observed in the offspring of survivors of the Dutch Hunger Winter, as mentioned above.

Igf2 is a paternally expressed imprinted gene. As shown in the figure below, under normal human physiological conditions, the imprinting control region (ICR) of the maternal Igf2 allele is unmethylated, allowing the regulatory protein CTCF to bind to the ICR. This binding blocks downstream enhancers from accessing the Igf2 gene, thereby preventing its expression. In contrast, the paternal ICR is methylated; the steric hindrance caused by methylation prevents the regulatory protein from binding to the ICR. Consequently, downstream enhancers can access the Igf2 gene and initiate the expression of growth factors essential for growth and development. In simple terms,Igf2 is a paternally imprinted gene that is expressed, while the maternally imprinted allele is not expressed.

In 2008, researchers compared the methylation levels in the Igf2 regulatory region between offspring conceived during the Great Famine and their siblings. The results showed that the methylation levels in offspring conceived during the Great Famine were significantly lower than those in their siblings who were not exposed to the famine.

It can be inferred that the fathers of these children, during the Great Famine,Dietary deficiency in key methyl donors for DNA methylation, such as methionine,Hypomethylation of the Igf2 regulatory region in sperm. During the Great Famine, fathers transmitted this hypomethylated state to their offspring. Consequently, the hypomethylated state was stably replicated and maintained in the offspring.

Insufficient methylation in the imprinted gene regulatory regions of offspring leads to reduced growth factor expression, manifesting as short stature (reduced energy intake) and a predisposition to obesity (increased energy storage). This appears to be an “adaptation” to the famine conditions experienced by the parental generation. It also highlights a key function of epigenetics: enhancing the adaptability of offspring, albeit potentially limited to adjacent generations.

◆ Histone Modification

Histone modification refers to the post-translational modification of side-chain groups (such as amino groups) on histone tails, primarily includingMethylation, Acetylation, Phosphorylation, and Ubiquitinationetc.

Histones and DNA can be understood as being connected through electrostatic adsorption.Histone ModificationModifications occur at their tails by regulating histone charge, weakening the interaction between nucleosomes and extrinsic proteins, and recruiting proteins to form complexes.Affects the three-dimensional structure of chromosomes and regulates gene expression.

In fact, in addition to regulating transcription, these modification functions also play important roles in DNA replication and repair, as well as in maintaining genomic stability. They are simultaneously involved in epigenetic regulation and DNA repair processes.This has made the relevant enzymes a popular target for oncology drug development.We will continue to discuss the critical role of epigenetic regulation in understanding oncological diseases.

◆ Interactions Between Non-coding RNAs and Chromatin

Non-coding RNAs are a class of RNAs that lack the capacity to encode functional proteins or peptides, and they regulate gene expression at both the DNA and mRNA levels.

Compared with DNA methylation and histone modifications, non-coding RNAs (ncRNAs) are highly diverse; however, due to base complementarity, they can recognize specific DNA sequences, thereby enabling ncRNAs to exert specific regulatory effects. Meanwhile, unlike DNA methylation and histone modifications, which generally target one or a few gene loci, ncRNAs can not only modulate the activity of individual genes but alsoRegulation of whole-chromosome activity.Currently, our understanding of non-coding RNAs lags behind that of DNA methylation and histone modifications.

Non-coding RNAs are generally classified into three categories: housekeeping non-coding RNAs, such as tRNAs responsible for transporting amino acids during protein assembly; small RNAs, such as circular RNAs and miRNAs; and long non-coding RNAs, which have been relatively less studied.

The coat color of calico cats is determined by a segment ofThe Long Non-coding RNA Named XistRegulation-induced; Xist is also the second long non-coding RNA discovered in humans.。This RNA is present in the female body,Capable of binding to a single chromosome and repeatedly coiling,Inducing transcriptional silencing of the majority of genes on one X chromosome。The physiological significance of this phenomenon lies in the fact that males possess only one X chromosome, whereas females have two. Inactivation of one X chromosome results in transcriptional silencing, thereby achieving dosage compensation of gene expression between the sexes.

Why do some calico cats express black fur while others express yellow, rather than a brown mixture of both? This is because one of the two X chromosomes, which separately encode the genes for black and yellow pigmentation, undergoes inactivation. This inactivation occurs randomly. The patchy appearance of black and yellow fur in calico cats is likely due to X-chromosome inactivation taking place early in development, with this inactivated state being stably inherited. Consequently, daughter cells maintain the same fur color phenotype after division.

In 1942, biologist Waddington proposed the concept of “epigenetics.” Since then, epigenetics has made continuous progress in specialized areas such as key species and mechanisms, sequencing and imaging technologies, molecular regulation tools, and clinical testing and drug development applications, undergoingThe Evolutionary Trajectory from Observation and Measurement to Manipulation and Manufacturing.

From the late 20th to the early 21st century, key players (such as DNA and histone methyltransferases) and mechanisms (such as long non-coding RNA-mediated chromosomal inactivation) involved in epigenetic modifications gradually became well defined. Attention increasingly focused on the functional consequences of these factors and mechanisms on chromatin. Sequencing and imaging technologies for studying complex chromatin structure, sequence, and positioning have advanced rapidly.

These advances in “measurement endpoints” have accumulated a vast amount of data for epigenetics.. On one hand, it is the first to be translated into clinical applications,Clinical diagnostic products, including fluorescence in situ hybridization (FISH) gene testing and tumor DNA methylation assays, as well as therapeutic agents such as histone deacetylase inhibitors (e.g., chidamide), have emerged.

On the other hand,Advances in measurement technologies have also driven research into the causal relationships between epigenetic modifications (DNA methylation, histone modifications, and non-coding RNA–chromatin interactions) and cellular phenotypes.For example, at the molecular level, CRISPR technology has becomeAs one of the precise and effective “manipulation” tools for epigenetic modifications. The accumulating research data on these molecular regulatory tools are expected to drive the emergence of next-generation epigenetic drugs and clinical diagnostic technologies.

Overall, the development of epigenetics rests on two major foundations.On the demand side, there is a strong demand for diagnosis and treatment of complex diseases such as tumors, neurological disorders, and immune diseases, driven by the exploration of complex developmental regulatory mechanisms.On the technical front, continuous advancements are being made in the analysis of keystone species, high-throughput sequencing, high-resolution imaging, and molecular tools. In the future, both demand-side and technology-side factors will continue to drive the development of epigenetics.

As mentioned above, the three major molecular regulatory mechanisms—DNA modification, histone modification, and non-coding RNA—affect epigenetics at the microscopic level. At the mesoscopic level, epigenetics is primarily observed and manipulated through chromatin and its nucleosome units.

In the field of epigenetics,Research MethodsIt remains a hotly debated field that is continuously evolving. Epigenetics takes chromatin as its research subject, and methods for analyzing chromatin are primarily divided into two categories,First, microscopy-based direct observation of the spatial architecture of chromatin; second, integration with high-throughput sequencing to directly or indirectly determine chromatin sequences, modifications, and morphology.

Over the past decade, a series of sequencing and microscopic observation techniques have been developed based on classical methods, driving progress in research. On the scientific research front, three major trends are emerging: first, the development ofBetter Molecular Tools, fundamentally enhanceAccuracy; second, toSingle-cell/pauci-cell, high-throughput, and high signal-to-noise ratio development; third, the integration of imaging and sequencing，It simultaneously provides multi-dimensional information, including sequencing data and spatial localization of cells. For instance, we have observed the continuous iteration and widespread adoption of DNA methylation sequencing tools (such as BS-seq and DM-seq), histone modification sequencing tools (such as CUT&Tag), and chromatin accessibility sequencing tools (such as ATAC-see).

From the industry perspective, we need to focus onHow to Reduce Costs and Address Practical Clinical Challenges. For instance, in the IVD field, applications based on epigenetics are still relatively limited, primarily focusing on fluorescence in situ hybridization (FISH) genetic testing and tumor gene DNA methylation detection.

The environment in which an organism lives often subtly influences gene expression, thereby altering its development and environmental adaptability, a process closely related to epigenetic modifications. Similarly, humans perceive their environment in complex ways. Factors such as dietary habits, chronic diseases, long-term medication use, anxiety and stress, lifestyle, and geographic location can all modify our individual gene expression.

At the disease level,Drug Resistance in Tumors (Dysdifferentiation Disorders), Immune System Dysfunction, and the Disease Progression of Neurodevelopmental and Neurodegenerative Disordersis also associated with this mechanism. Therefore, research in epigenetics holds implications for the diagnosis and treatment of related diseases, as well as for drug development.

Diseases caused by aberrant epigenetic modifications can be classified into two categories: one caused by genetic mutations, and the other by epimutations, in which no genetic mutations occur.

The first category of diseases involves mutations in the genes encoding epigenetically modified functional proteins and molecular components (such as non-coding RNAs), including cancers and developmental disorders.When studying such diseases, we need to focus more on mutated genes and conduct targeted drug development.

Tumors can be regarded as a disorder of cellular differentiation.These abnormalities are often associated with epigenetic modifications, such as DNA methylation and histone acetylation. Therefore, drugs developed targeting DNA methyltransferases/demethylases and histone-modifying enzymes theoretically offer superior target specificity. Moreover, from a structural perspective, these epigenetic targets exhibit greater druggability compared to transcription factors. Consequently, they have attracted significant interest from pharmaceutical companies in the development of chemical targeted therapies over the past few decades.

According to public data, as of August 2023, two drugs targeting DNA methyltransferases, five drugs targeting histone deacetylases, and one drug targeting histone methyltransferases have been approved for marketing. Based on a summary of drug labels issued by the U.S. Food and Drug Administration (FDA) and China’s National Medical Products Administration, drugs targeting histone-modifying enzymes generally demonstrate an objective response rate (ORR) of 30%–35% and a complete response rate (CR) of less than 10% in pivotal clinical trials involving monotherapy. Drugs targeting DNA methyltransferases exhibit relatively weaker efficacy.

A major challenge in developing drugs targeting epigenetic sites is that, although the biochemical mechanisms of target proteins in epigenetic modifications are relatively clear, there may be other mechanisms in cell biology and disease physiology, making off-target effects of drugs relatively difficult to avoid. Drug optimization needs to be based on further biological/physiological research.

It is worth mentioning that,Chidamide is the first original chemical drug approved for marketing in China.The primary indication is peripheral T-cell lymphoma, which was later expanded to include breast cancer. Chidamide targetsHDAC, the key enzyme regulating gene expression,It can inhibit tumor cell division, induce apoptosis, and simultaneously mitigate the development of drug resistance. According to clinical research data published in the “Chinese Expert Consensus on Chidamide for the Treatment of Peripheral T-Cell Lymphoma (2018 Edition),” the objective response rate (ORR) in patients receiving chidamide monotherapy was 47%. Combination therapy demonstrated superior efficacy compared with monotherapy, with studies showing that the ORR for various chidamide-based combination regimens exceeded 60%.

The second category is epimutations,This generally refers to abnormalities in the epigenetic modifications of specific genes during developmental reprogramming, in the absence of genetic sequence mutations, as seen in conditions such as autoimmune diseases and neurodegenerative disorders. The etiologies of most such diseases are complex, involving interactions between the human body and factors such as age, the natural environment, and even the social environment. Epigenetic research provides new perspectives for understanding disease mechanisms and developing novel therapeutic agents.

Autoimmune DiseasesAutoimmune diseases arise from the immune system mistakenly attacking healthy tissues, leading to damage in tissues and organs. According to research by scholars such as Glinda S. Cooper and Milele L.K. Bynum, more than 100 autoimmune diseases have been identified, threatening the health of over 500 million people worldwide. Studies indicate that environmental factors are significant contributors to the pathogenesis of autoimmune diseases, among which epigenetic modification, specifically DNA methylation, is closely associated with the onset and progression of these conditions.

Systemic Lupus ErythematosusIt is a typical autoimmune disease, characterized primarily by the massive production of autoantibodies and inflammatory damage, affecting multiple organs and systems. Research evidence from recent decades indicates that,Pathological Hypomethylation of T-Cell DNA Plays a Key Role in Disease Progression.In animal models, artificial induction of DNA hypomethylation to mimic the same pathogenic mechanism can activate the expression of specific immune-related genes in normal T cells, leading to similar symptoms.

Psoriasis, another autoimmune disease, is a common chronic, relapsing inflammatory skin disorder characterized by hypertrophic erythematous plaques and silvery-white scales. Studies have found that, compared with normal skin,Whole-genome DNA from the patient's skin lesions exhibits hypermethylation.This hypermethylated state may lead to widespread alterations in the proliferation and differentiation of keratinocytes, which are closely associated with skin lesions in patients.

Neurodegenerative Diseasesreferring to the human brain, spinal cord, or peripheral nervous systemNeurons lose function and gradually die over time.a class of diseases.Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS)...are all classified as neurodegenerative diseases. Advanced age is one of the significant risk factors influencing the onset of neurodegenerative diseases. During the aging process, chromosomal structure undergoes alterations, which serve as one of the key triggers for the decline in brain function.

With population aging and increasing life expectancy,In the coming decades, more people will be affected by neurodegenerative diseases.Alzheimer’s disease (AD) is the leading cause of dementia in adults aged 65 and older, characterized by cognitive impairments such as deficits in learning and memory. Studies have shown thatThe occurrence of Alzheimer's disease is associated with abnormal histone modifications.Postmortem hippocampal samples from patients with Alzheimer’s disease (AD) show upregulated levels of histone deacetylase 2 (HDAC2). In mouse models simulating AD, upregulation of HDAC2 impairs hippocampal synaptic function; conversely, downregulation of HDAC2 increases hippocampal synaptic density, thereby alleviating memory deficits.

In the biopharmaceutical sector, genomics is one of the disciplines that can be compared with epigenetics. The field of genomics has given rise to successful companies such as Illumina and BGI Genomics. By comparison, we believe that epigenetics also holds significant potential for development.

First,From the Perspective of Complexity, genomics focuses on DNA sequences,The chromatin structure in epigenetic research is a more complex system.If DNA research focuses on one-dimensional sequence arrangements, epigenetics encompasses not only one-dimensional modifications but also two-dimensional interactions, as well as three-dimensional spatial structures and intracellular localization.

Second,In terms of approach,Epigenetics focuses on cellular plasticity. While genomics concentrates on relatively stable “gene annotations,” epigenetics emphasizes “dynamics” and “adaptation,” aligning more closely with the physiological characteristics of diseases such as cancer and neurodegenerative disorders. In the future, epigenetics may yield many new discoveries.

Third, epigeneticsDetection methods are more diverse.In addition to sequencing, epigenetics can provide multidimensional information through imaging techniques, thereby enhancing the potential for clinical translation.

What Are the Future Development Prospects of Epigenetics?

First, epigenetic modifications confer cellular plasticity, that is, the capacity and speed with which an individual adapts to the environment. In this sense, epigeneticsin oncology, neurological disorders, and immune system diseases, etc.There will be promising development prospects in diseases related to metabolic and differentiation disorders.

From the perspective of the overall industry,The field of epigenetics is still in its early stages of development.Progress has been largely confined to academic institutions, with relatively limited translation into industrial applications. Current uses are primarily concentrated in the research testing market; clinical testing content and methodologies remain limited, and drug development is mainly based on correlational relationships. To avoid fragmented or overly generalized interpretations, new translational applications should adopt a more macroscopic perspective to understand the impact of epigenetic technologies and principles on biological systems. For instance, attention should be focused on the regulation of overall chromatin structure (rather than changes in the methylation status of individual genes) and on the abundance regulation of the entire miRNA repertoire (rather than changes in the abundance of single miRNAs).

On the research front, new testing tools and methodologies will continue to emerge.Moving toward single-cell and high-throughput approaches. These new methods and tools are likely to significantly reduce costs. Epigenetics is an “omics” discipline that encompasses not only one-dimensional sequences but also two-dimensional chromosome contact frequencies and three-dimensional spatial conformations and intracellular localization. Discovering patterns across higher and more diverse dimensions may become a prevailing research trend.

On the clinical side, epigenetics is closely related to individual adaptability.In terms of detection and diagnosis,Promising avenues for exploration include leveraging epigenetic sequencing data to guide monotherapy or combination therapy regimens, as well as utilizing epigenetic modifications for early screening of tumors, autoimmune diseases, and other conditions.

In drug development,Opportunities remain for developing drugs based on epigenetic targets. The current challenge lies in the relatively insufficient research on the specificity of targets associated with diseases. While the biochemical effects of epigenetic modifications are relatively well understood, their cytological roles and implications in disease pathology have not been fully elucidated. Clinically, it remains difficult to optimize the efficacy and safety of existing epigenetic-targeted therapies, underscoring the need for continued exploration of the underlyingCellular Biological Mechanisms.

Currently, we have identified several promising avenues in epigenetics worth exploring. For instance, by integrating the perspective of epigenetic regulation of individual adaptability, we can investigate the critical roles of these targets in mechanisms such as the development of tumor drug resistance. This approach can guide the design of combination therapies to enhance tumor sensitivity to therapeutic agents and delay the onset of resistance. Furthermore, by combining epigenetic targets with other cellular regulatory elements, we may improve the specificity of epigenetic drugs, thereby facilitating the development of therapeutics targeting interspecies interactions, such as protein-protein interactions.

In the future, we will continue to focus onEpigeneticsDevelopment in the scientific research and industrial sectors will also continue to explore other emerging areas still in their growth phase,Focus on high-potential niches in the life sciences sector, doing what is right rather than what is easy.